fig1
![Introduction to 2023 Chinese expert consensus on the whole-course management of hepatocellular carcinoma](https://image.oaes.cc/0b2c0d4f-a99c-485e-97ac-90c10c65ef51/hr1016.fig.1.jpg)
Figure 1. Whole-course management of HCC with curative therapy as the goal. a: exploration stage; b: Patients eligible for liver transplantation: Milan criteria/University of California, San Francisco (UCSF) criteria/Chinese criteria; BCLC: Barcelona clinic liver cancer; CNLC: China liver cancer staging.